Amphastar Pharmaceuticals, Inc. (AMPH) — Analysis Summary
Amphastar Pharmaceuticals, Inc. (AMPH) has a market cap of $869.07M with year-over-year revenue growth of -1.7%. Net margin stands at 13.6%. The stock trades at a P/E ratio of 11.0.
Key Takeaways
- Revenue changed -1.7% year-over-year
- Net margin of 13.6%
- P/E ratio of 11.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, AMPH posted revenue growth of -1.7% and trades at a P/E of 11.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.